Conference Description
The Neurobiology of Brain Disorders GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
The global challenge presented by neurodegenerative disorders is immense but the application of new molecular and cellular technologies is revealing important mechanistic insights. The temporal evolution of disease is being mapped at single-cell and tissue levels by multi-omic techniques. Key molecular interactions are being identified as drug targets and novel therapeutic approaches are being developed. These studies have highlighted disturbances in RNA metabolism, intracellular transport, proteostasis, inflammation and the role of aging. The 2024 Gordon Conference on Neurobiology of Brain Disorders will bring together research leaders from a wide range of disciplines to discuss their latest findings and how they might translate into new therapies. Invited speakers will be encouraged to present unpublished work and explore opportunities to collaborate. Junior scientists and graduate students are encouraged to submit abstracts for oral and poster presentations, and engage key opinion leaders in discussion. GRC conferences are famously informal and popular and they are always oversubscribed so early registration and abstract submission is advised.
The topics, speakers, and discussion leaders for the conference sessions are displayed below. The conference chair is currently developing their detailed program, which will include the complete meeting schedule, as well as the talk titles for all speakers. The detailed program will be available by April 6, 2024. Please check back for updates.
Keynote Session: Genetic Landscape of Neurodegenerative Disorders
Discussion Leaders
-
Philip De Jager (Columbia University Medical Center, United States)
Speakers
-
Alison Goate (Icahn School of Medicine at Mount Sinai, United States)
Recent Advances in Genetics and Genomic Approaches to Neurodegenerative Disease
Discussion Leaders
-
John Hardy (UCL Queen Square Institute of Neurology, United Kingdom)
Speakers
-
Emil Gustavsson (University College London, United Kingdom)
-
Philip De Jager (Columbia University Medical Center, United States)
-
Mie Rizig (University College London, United Kingdom)
-
Catherine Kaczorowski (University of Michigan, United States)
-
Sarah Marzi (King's College London, United Kingdom)
Contribution of Aging to Neurodegenerative Disease
Discussion Leaders
-
Hemali Phatnani (Columbia University/New York Genome Center, United States)
Speakers
-
Giovanna Mallucci (Altos Labs, United Kingdom)
-
Miranda Orr (Wake Forest University School of Medicine, United States)
-
Ian Guldner (Stanford University, United States)
Frontotemporal Dementia and ALS Mechanistic Updates
Discussion Leaders
-
Michael Ward (National Institutes of Health, United States)
Speakers
-
Christian Haass (Ludwig Maximilians University of Munich, Germany)
-
Philip Wong (Johns Hopkins Medicine, United States)
-
Jan Veldink (Department of Neurology, University Medical Center Utrecht, The Netherlands, The Netherlands)
Parkinson’s Disease: Mechanistic Updates
Discussion Leaders
-
Mark Cookson (National Institute on Aging, NIH, United States)
Speakers
-
Tim Bartels (University College London / Dementia Research Institute, United Kingdom)
-
Sonia Gandhi (UCL & The Francis Crick Institute, United Kingdom)
Alzheimer’s Disease: Mechanistic Updates
Discussion Leaders
-
Bart De Strooper (VIB and KU Leuven, Belgium)
Speakers
-
Soyon Hong (UK Dementia Research Institute, University College London, United Kingdom)
-
Michael Heneka (Université du Luxembourg, Luxembourg)
-
Yakeel Quiroz (Massachusetts General Hospital, United States)
-
David Holtzman (Washington University in St. Louis, United States)
Tauopathies: Mechanistic Updates
Discussion Leaders
-
David Holtzman (Washington University in St. Louis, United States)
Speakers
-
Rene Frank (University of Leeds, United Kingdom)
-
Li Gan (Weill Cornell Medicine, United States)
-
Andrew Yoo (Washington University School of Medicine, United States)
Biomarkers: Diagnosis and Theranostics
Discussion Leaders
-
Stephanie Fradette (Biogen, United States)
Speakers
-
Henrik Zetterberg (UCL, United Kingdom)
-
Elisa Konofagou (Columbia University, United States)
Novel Therapeutic Approaches
Discussion Leaders
-
Eric Karran (Eli Lilly, United Kingdom)
Speakers
-
Stephanie Fradette (Biogen, United States)
-
Stefan Pulst (University of Utah, United States)
-
Adrian Krainer (Cold Spring Harbor Laboratory, United States)
-
Li-Huei Tsai (Picower Institute for Learning and Memory, Massachusetts Institute of Technology, United States)
The GRC Power Hour™
Organizers
-
Hemali Phatnani (Columbia University/New York Genome Center, United States)